Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase II Trial of Preoperative FOLFIRINOX Followed by Gemcitabine Based Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Adenocarcinoma

Summary

The purpose of this phase II trial is to study the effectiveness of the combination chemotherapy, gemcitabine hydrochloride, and radiation therapy before surgery in treating patients with borderline resectable pancreatic cancer.

General Information

NCT#: NCT01897454
Study ID: 2013-01213-12-017
Trial Phase: Phase II

Trial Sponsor: Montefiore Medical Center
Therapies Used in This Trial: Fluorouracil, Gemcitabine, Intensity modulated radiation therapy (IMRT), Oxaliplatin, Irinotecan, Leucovorin, FOLFIRINOX

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search